Radiometal labeled agents (non-technetium) for diagnostic imaging

[1] ALAZRAKI NP, 1995, PRINCIPLES PRACTICE

[2] HYDROXAMATKOMPLEXE .2. DIE ANWENDUNG DER PH-METHODE [J]. HELVETICA CHIMICA ACTA, 1963, 46 (04) : 1400 - &

[3] Anderson C.J., 1994, HDB METALS CLIN ANAL

[4] Anderson CJ, 1998, J NUCL MED, V39, P1944

[5] ANDERSON CJ, 1995, J NUCL MED, V36, P2315

[6] EVALUATION OF COPPER-LABELED BIFUNCTIONAL CHELATE ALBUMIN CONJUGATES FOR BLOOD POOL IMAGING [J]. NUCLEAR MEDICINE AND BIOLOGY, 1993, 20 (04): : 461 - 467

[7] Axworthy D, 1996, TUMOR TARGET, V2, P156

[8] Axworthy DB, 1994, J IMMUNOTHER, V16, P158

[9] BAKKER WH, 1991, J NUCL MED, V32, P1184

[10] [IN-111-DTPA-D-PHE1]-OCTREOTIDE, A POTENTIAL RADIOPHARMACEUTICAL FOR IMAGING OF SOMATOSTATIN RECEPTOR-POSITIVE TUMORS - SYNTHESIS, RADIOLABELING AND INVITRO VALIDATION [J]. LIFE SCIENCES, 1991, 49 (22) : 1583 - 1591

[1] ALAZRAKI NP, 1995, PRINCIPLES PRACTICE

[2] HYDROXAMATKOMPLEXE .2. DIE ANWENDUNG DER PH-METHODE [J]. HELVETICA CHIMICA ACTA, 1963, 46 (04) : 1400 - &

[3] Anderson C.J., 1994, HDB METALS CLIN ANAL

[4] Anderson CJ, 1998, J NUCL MED, V39, P1944

[5] ANDERSON CJ, 1995, J NUCL MED, V36, P2315

[6] EVALUATION OF COPPER-LABELED BIFUNCTIONAL CHELATE ALBUMIN CONJUGATES FOR BLOOD POOL IMAGING [J]. NUCLEAR MEDICINE AND BIOLOGY, 1993, 20 (04): : 461 - 467

[7] Axworthy D, 1996, TUMOR TARGET, V2, P156

[8] Axworthy DB, 1994, J IMMUNOTHER, V16, P158

[9] BAKKER WH, 1991, J NUCL MED, V32, P1184

[10] [IN-111-DTPA-D-PHE1]-OCTREOTIDE, A POTENTIAL RADIOPHARMACEUTICAL FOR IMAGING OF SOMATOSTATIN RECEPTOR-POSITIVE TUMORS - SYNTHESIS, RADIOLABELING AND INVITRO VALIDATION [J]. LIFE SCIENCES, 1991, 49 (22) : 1583 - 1591